Article
Differentiation Potential of Mesenchymal Stem/Stromal Cells Is Altered by Intrauterine Growth Restriction
5 Nov 2020
Abstract excerpt
Consistency in clinical outcomes is key to the success of therapeutic Mesenchymal Stem/Stromal cells (MSCs) in regenerative medicine. MSCs are used to treat both humans and companion animals, horses, dogs and cats. The properties of MSC preparations can vary significantly with factors including tissue of origin, donor age or health status. We studied the effects of developmental programming associated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
